For the Inventor, By the Inventor

Enter assignee name

Cleveland, OH, United States of America

Athersys, Inc.

USPTO Granted Patents = 32

% Expired Patents = 53.1

EPO Patents = 10

Forward Citations = 194

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Youssef L Bennani (15 out of 36 patents)

John Joseph Harrington (12 out of 24 patents)

Stephen Rundlett (10 out of 13 patents)

4. Bruce Sherf (9 out of 12 patents)

5. Michael J Robarge (8 out of 20 patents)

6. David C Bom (6 out of 10 patents)

7. Michael G Campbell (6 out of 8 patents)

8. Robert J Deans (5 out of 17 patents)

9. David Dastrup (5 out of 5 patents)

10. Richard Maziarz (4 out of 5 patents)

11. Magdalena Kovacsovics (4 out of 5 patents)

12. Wouter Van't Hof (4 out of 5 patents)

13. Bayard R Huck (4 out of 36 patents)

14. Emilie Porter Huck (4 out of 6 patents)

15. Philip R Streeter (4 out of 8 patents)

32 patents: Sort by Forward Citations

1. 11000546 - Immunomodulatory properties of MAPCs and uses thereof (2021-05-11),

2. 10117900 - MAPC treatment of brain injuries and diseases (2018-11-06),

3. 9962407 - Immunomodulatory properties of multipotent adult progenitor cells and uses thereof (2018-05-08),

4. 9808485 - Immunomodulatory properties of multipotent adult progenitor cells and uses thereof (2017-11-07),

5. 8716324 - Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators (2014-05-06),

6. 8716276 - [object Object] (2014-05-06),

7. 8232311 - Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators (2012-07-31),

8. 8147824 - Immunomodulatory properties of multipotent adult progenitor cells and uses thereof (2012-04-03),

9. 8129424 - Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders (2012-03-06),

10. 7981919 - Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators (2011-07-19),

11. 7981896 - Pyrazoles for the treatment of obesity and other CNS disorders (2011-07-19),

12. 7947691 - Cyclic n-hydroxy imides as inhibitors of flap endonuclease and uses thereof (2011-05-24),

13. 7935830 - Tricyclic indeno-pyrrole derivatives as serotonin receptor modulators (2011-05-03),

14. 7897634 - Pyrazoles for the treatment of obesity and other CNS disorders (2011-03-01),

15. 7893051 - [object Object] (2011-02-22),

Athersys, Inc. is a biotechnology company engaged in the discovery and development of therapies focused on improving patients' health and quality of life. They use their proprietary MultiStem platform to develop regenerative medicine products for various conditions, including neurological, cardiovascular, inflammatory, and immune disorders.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

32 Patents

#66 in Cleveland, OH

#463 in Ohio

#10,575 in US

#20,620 in the World

Cleveland, OH, United States of America

Athersys, Inc.

Forward Citations = 194

25 inventors:

Youssef L Bennani (15 out of 36 patents)

John Joseph Harrington (12 out of 24 patents)

Stephen Rundlett (10 out of 13 patents)

4. Bruce Sherf (9 out of 12 patents)

5. Michael J Robarge (8 out of 20 patents)

Please report any incorrect information to [email protected]

Loading…